(Q33523990)

27 July 2017

Polypoidal choroidal vasculopathy: an angiographic discussion (English)

1 reference

27 July 2017

1 reference

T H Lim

1

1 reference

27 July 2017

A Laude

series ordinal

2

1 reference

27 July 2017

C S H Tan

series ordinal

3

1 reference

27 July 2017

15 January 2010

1 reference

27 July 2017

1 reference

27 July 2017

24

1 reference

27 July 2017

3

1 reference

27 July 2017

483-490

1 reference

https://scigraph.springernature.com/pub.10.1038/eye.2009.323

27 July 2017

0 references

cites work

Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Idiopathic polypoidal choroidal vasculopathy as a cause of a disciform macular scar

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy with drusen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy: natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

A classification system for polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy in Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Idiopathic polypoidal choroidal vasculopathy: a disease with diverse clinical spectrum and systemic associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Pathological features of surgically excised polypoidal choroidal vasculopathy membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Clinicopathologic findings in polypoidal choroidal vasculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

A study of laser photocoagulation for polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy with large vascular network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

The origins of polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Short-term safety and efficacy of a single intravitreal bevacizumab injection for the management of polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy in elderly Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Clinical characteristics of exudative age-related macular degeneration in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Subtype lesions of neovascular age-related macular degeneration in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Role of photodynamic therapy in polypoidal choroidal vasculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

Polypoidal choroidal vasculopathy causing massive suprachoroidal haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Idiopathic polypoidal choroidal vasculopathy in Japanese patients

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Peripheral idiopathic polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Idiopathic polypoidal choroidal vasculopathy associated with retinal arterial macroaneurysm and hypertensive retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Laser photocoagulation in idiopathic polypoidal choroidal vasculopathy. Over one year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Short-term anatomic effect of ranibizumab for polypoidal choroidal vasculopathy.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.323

7 January 2021

Identifiers

DOI

10.1038/EYE.2009.323

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference